Moreover, CD103+CD39+CD8+ TILs displayed more clonal expansion and better tumor antigen recognition than CD103-CD39-CD8+ TILs, indicating that CD103+CD39+CD8+ TILs were enriched with tumor specific T cells (44, 58). The gene discussed is ENTPD1; the disease is neoplasm.